Hypera S.A. is a prominent player in the pharmaceutical industry, primarily engaged in the development, production, and marketing of a diverse range of healthcare products. It operates as a leading ph... Hypera S.A. is a prominent player in the pharmaceutical industry, primarily engaged in the development, production, and marketing of a diverse range of healthcare products. It operates as a leading pharmaceutical company in Brazil, well known for its extensive portfolio that includes medications, vitamins, dermocosmetic products, and nutritional supplements. Hypera's primary function is to address the health and wellness needs of consumers by producing efficient and innovative healthcare solutions. The company focuses on over-the-counter (OTC) products, prescription drugs, and generic medicines, impacting various sectors such as consumer health and personal care. Hypera S.A. is essential to the Brazilian healthcare market, serving as a significant contributor to the pharmaceutical industry by ensuring accessibility and quality of health products. Its operations and products play a pivotal role in providing affordable healthcare solutions, supporting public health initiatives, and responding to the increasing demand for quality pharmaceuticals in Brazil and the broader Latin American region.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

Hypera is not subject to EU Taxonomy reporting

Based on current regulatory requirements, Hypera is not required to report EU Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU Taxonomy data review for this company.

If you believe this assessment should be revisited, you may submit a data coverage request and our team will review the company's regulatory applicability.

Would you like us to review Hypera's data?

Start your 30-day free trial to request a data review for Hypera.

Start Free Trial

Legal Center Contact Us